To contribute to the growing body of research on the regulation of immune checkpoints in cancers, our study focused on assessing the prognostic relevance of the candidate genes PD-L1, PD-1, FOXP3, and miR-155 in HPV-negative OSCC by integrating gene expression analysis, genetic variations, and patients’ survival. Here, PDCD1 is linked to cancer.